Updated: Mar 9, 2026

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
Kadijeh Tati1, Mahsa Yazdanpanah-Samani2, Amin Ramezani3
1Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical sciences, Shiraz, Iran; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers cloned and expressed the human CD52 gene in CHO cells, creating a CD52-positive cell line. This advancement aids in developing diagnostic tools and potential antibody therapies for CD52-related conditions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: